Form 4: CME Group CEO Duffy Acquires Shares, Sells for Tax

CME Group Chairman and CEO Terrence A. Duffy acquired 62,902 shares through performance share vesting and subsequently disposed of 27,866 shares for tax withholding obligations.

Summary

• Terrence A. Duffy, Chairman and CEO of CME Group Inc., acquired 62,902 shares of Class A Common Stock on March 15, 2026.
• This acquisition resulted from the vesting of performance shares granted in 2022 under CME Group's Omnibus Stock Plan.
• The number of vested shares was determined by the company's Total Shareholder Return (TSR) performance relative to the S&P 500 over a three-year period from January 1, 2023, through December 31, 2025.
• Concurrently, Mr. Duffy disposed of 27,866 shares of Class A Common Stock on March 15, 2026, to cover tax withholding obligations related to the performance share award.
• The transaction price for both the acquisition and disposition was $311.4 per share.
• Following these transactions, Mr. Duffy directly beneficially owns 90,630 shares of Class A Common Stock.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a moderately positive signal, indicating that CME Group met its performance targets for the 2023-2025 period, leading to the vesting of executive performance shares. The subsequent sale for tax purposes is a routine event.

Positives

• The vesting of 62,902 performance shares indicates that CME Group achieved its Total Shareholder Return (TSR) targets relative to the S&P 500 over the 2023-2025 performance period.
• This demonstrates successful execution against long-term incentive goals, aligning management interests with shareholder value creation.

Negatives

• A portion of the acquired shares (27,866 shares) was immediately sold to cover tax withholding obligations, which is a common practice but reduces the net increase in direct beneficial ownership.

Future Outlook

NA

Industry Context

StockSavvy.ai notes that insider transactions, particularly those related to executive compensation and performance-based awards, are common across the financial services industry. The vesting of performance shares tied to relative TSR performance is a standard practice designed to align executive incentives with long-term shareholder value, a trend widely adopted by major exchanges and financial infrastructure providers like CME Group.

Comparison to Industry Standards

• The use of Total Shareholder Return (TSR) relative to a broad market index like the S&P 500 for executive performance share vesting is a widely accepted best practice in corporate governance and executive compensation across global financial markets. Companies such as Intercontinental Exchange (ICE) and Nasdaq (NDAQ) also frequently utilize similar performance metrics for their long-term incentive plans to ensure alignment with shareholder interests.
• The immediate disposition of shares to cover tax withholding obligations upon vesting is a standard and expected procedure for equity awards, consistent with practices observed at peer companies and across various industries.

Stakeholder Impact

• Shareholders: The vesting of performance shares suggests the company achieved its TSR targets relative to the S&P 500, which is generally positive for shareholders as it indicates management's performance aligns with shareholder returns.
• Management/Executives: Terrence A. Duffy received a significant equity award, reinforcing his compensation structure and alignment with company performance.

Key Dates

Recommendation

This Form 4 filing details a routine executive compensation event where performance shares vested due to the company meeting its targets, followed by a standard tax-related sale. It does not provide new fundamental information about CME Group's operational performance or strategic direction that would warrant a change in investment recommendation. The transaction is an expected outcome of a pre-existing compensation plan, reinforcing a 'hold' stance for investors awaiting broader financial updates.

Keywords

CME Group, Terrence A. Duffy, Form 4, Insider Trading, Performance Shares, Stock Vesting, Executive Compensation, Shareholder Return, CME